Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Condensed Consolidated Statements of Changes in Shareholders' Equity (Unaudited)

v3.24.3
Condensed Consolidated Statements of Changes in Shareholders' Equity (Unaudited) - GBP (£)
Common Stock [Member]
Deferred Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Balance at Dec. 31, 2022 £ 95 £ 397,398 £ 33,308,568 £ (33,374,796) £ 331,265
Balance, shares at Dec. 31, 2022 949,958 794,955      
Share-based compensation expense 142,321 142,321
Share-based compensation expense, shares        
Issuance of ordinary shares, net of issuance costs £ 485 1,536,360 1,536,845
Issuance of ordinary shares, net of issuance costs, shares 4,849,340      
Net income (loss) 357,976 357,976
Balance at Jun. 30, 2023 £ 580 £ 397,398 34,987,249 (33,016,820) 2,368,407
Balance, shares at Jun. 30, 2023 5,799,298 794,955      
Balance at Dec. 31, 2023 £ 2,057 £ 397,398 41,123,065 (38,837,290) 2,685,230
Balance, shares at Dec. 31, 2023 20,570,088 794,955      
Share-based compensation expense 908,613   908,613
Share-based compensation expense, shares        
Net income (loss) (5,308,407) (5,308,407)
Shares issued in connection with Series D warrant exercise, net of issuance costs £ 1,248 911,544 912,792
Shares issued in connection with Series D warrant exercise, net of issuance costs, shares 12,475,000        
Shares issued in connection with Series E warrant exercise, net of issuance costs £ 3,500 2,782,694 2,786,194
Shares issued in connection with Series E warrant exercise, net of issuance costs, shares 35,000,000        
Shares issued in connection with exercise of prefunded warrants, deferred pension settlement and consulting services £ 3,086 16,679 19,765
Shares issued in connection with deferred pension, shares 30,857,553      
Balance at Jun. 30, 2024 £ 9,891 £ 397,398 £ 45,742,595 £ (44,145,697) £ 2,004,187
Balance, shares at Jun. 30, 2024 98,902,641 794,955